Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Syros Pharmaceuticals
Biotech
Incyte drops Syros blood cancer partnership, following Pfizer
Incyte has ended a five-year collaboration with Syros after seven targets were identified for blood cancer but none taken up for further development.
Annalee Armstrong
Aug 14, 2023 10:45am
Pfizer drops sickle cell collab with Syros inherited from GBT
Jul 24, 2023 10:23am
3 more biotechs look to cull, partner assets
Nov 14, 2022 11:40am
Syros buys Tyme, securing $190M to extend cash runway into 2025
Jul 5, 2022 9:40am
Syros targets KRAS-mutant cancer with CDK7 inhibitor
Sep 20, 2021 11:30am
Syros links SY-1425 combo to 50%-plus AML complete response rate
Oct 25, 2019 10:15am
